☰

Priyanka Garg, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutics and Pharmaceutical Chemistry University of Utah, Salt Lake City, UT 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wu JC, Garg P, Yoshida Y, Yamanaka S, Gepstein L, Hulot JS, Knollmann BC, Schwartz PJ. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. Circulation Research. 125: 653-658. PMID 31465267 DOI: 10.1161/Circresaha.119.315209  0.342
2019 Lee J, Termglinchan V, Diecke S, Itzhaki I, Lam CK, Garg P, Lau E, Greenhaw M, Seeger T, Wu H, Zhang JZ, Chen X, Gil IP, Ameen M, Sallam K, et al. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature. PMID 31316208 DOI: 10.1038/S41586-019-1406-X  0.324
2019 Kernik DC, Morotti S, Wu H, Garg P, Duff HJ, Kurokawa J, Jalife J, Wu JC, Grandi E, Clancy CE. A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources. The Journal of Physiology. PMID 31278749 DOI: 10.1113/Jp277724  0.347
2018 Churko JM, Garg P, Treutlein B, Venkatasubramanian M, Wu H, Lee J, Wessells QN, Chen SY, Chen WY, Chetal K, Mantalas G, Neff N, Jabart E, Sharma A, Nolan GP, et al. Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis. Nature Communications. 9: 4906. PMID 30464173 DOI: 10.1038/S41467-018-07333-4  0.323
2018 Garg P, Garg V, Shrestha R, Sanguinetti MC, Kamp TJ, Wu JC. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists. Circulation Research. 123: 224-243. PMID 29976690 DOI: 10.1161/Circresaha.118.311209  0.582
2018 Garg P, Oikonomopoulos A, Chen H, Li Y, Lam CK, Sallam K, Perez M, Lux RL, Sanguinetti MC, Wu JC. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant. Journal of the American College of Cardiology. 72: 62-75. PMID 29957233 DOI: 10.1016/J.Jacc.2018.04.041  0.508
2018 Garg P. Abstract 256: Precision Medicine in Cardiac Channelopathy: Integrating Genome Editing and Induced Pluripotent Stem Cells to Decipher Variant of Unknown Significance Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.256  0.322
2016 Liang P, Sallam K, Wu H, Li Y, Itzhaki I, Garg P, Zhang Y, Vermglinchan V, Lan F, Gu M, Gong T, Zhuge Y, He C, Ebert AD, Sanchez-Freire V, et al. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome. Journal of the American College of Cardiology. 68: 2086-2096. PMID 27810048 DOI: 10.1016/J.Jacc.2016.07.779  0.336
2014 Garg P, Sanguinetti MC. Intracellular ATP does not inhibit Slo2.1 K+ channels. Physiological Reports. 2. PMID 25214519 DOI: 10.14814/Phy2.12118  0.582
2013 Garg P, Gardner A, Garg V, Sanguinetti MC. Structural basis of ion permeation gating in Slo2.1 K+ channels. The Journal of General Physiology. 142: 523-42. PMID 24166878 DOI: 10.1085/Jgp.201311064  0.582
2013 Garg P. Selectivity Filter Mediated Gating of Slo2.1 Channels is Modulated by Dynamic Rearrangement of S6 Segments Biophysical Journal. 104: 463a. DOI: 10.1016/J.Bpj.2012.11.2562  0.449
2012 Garg P, Sanguinetti MC. Structure-activity relationship of fenamates as Slo2.1 channel activators. Molecular Pharmacology. 82: 795-802. PMID 22851714 DOI: 10.1124/Mol.112.079194  0.572
2012 Garg P, Sanguinetti M. Pharmacology of Slo2.1 Channel Activation and Block Biophysical Journal. 102: 137a. DOI: 10.1016/J.Bpj.2011.11.757  0.592
Show low-probability matches.